Carcinostatic for hormonotherapy containing dienogest as effective component
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 29, 1997
Grant Date -
N/A
app pub date -
Nov 16, 1994
filing date -
Nov 19, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A carcinostatic for a hormonotherapy containing dienogest or its solvate, which is expected to exert therapeutic effects for a broad range of cancer cases at a far lower dose than that of conventional hormonotherapeutic agents and utterly free from side effects that the conventional high-dose hormonotherapy had suffered. ##STR1##
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully